The present disclosure relates to crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid, the process of preparing the forms, and pharmaceutical compositions and methods of use thereof.
本公开涉及[(
4-羟基-1-甲基-7-苯氧基-
异喹啉-3-羧酰基)-
氨基]-
乙酸的晶体固态形式,制备该形式的过程,以及其制备的药物组合物和使用方法。